+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Peripheral Guidewires - Medical Devices Pipeline Product Landscape, 2021

  • PDF Icon

    Report

  • 61 Pages
  • December 2021
  • Region: Global
  • GlobalData
  • ID: 5521336
The publisher's Medical Devices sector report, “Peripheral Guidewires - Medical Devices Pipeline Product Landscape, 2021' provides comprehensive information about the Peripheral Guidewires pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Peripheral Guidewires are used during percutaneous transluminal angioplasty (PTA) for guiding stents or balloon catheters to the site of blockage in the peripheral vasculature.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Peripheral Guidewires under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Peripheral Guidewires and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Peripheral Guidewires under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Peripheral Guidewires Overview
3 Products under Development
3.1 Peripheral Guidewires - Pipeline Products by Stage of Development
3.2 Peripheral Guidewires - Pipeline Products by Segment
3.3 Peripheral Guidewires - Pipeline Products by Territory
3.4 Peripheral Guidewires - Pipeline Products by Regulatory Path
3.5 Peripheral Guidewires - Pipeline Products by Estimated Approval Date
3.6 Peripheral Guidewires - Ongoing Clinical Trials
4 Peripheral Guidewires - Pipeline Products under Development by Companies
4.1 Peripheral Guidewires Companies - Pipeline Products by Stage of Development
4.2 Peripheral Guidewires - Pipeline Products by Stage of Development
5 Peripheral Guidewires Companies and Product Overview
5.1 Andramed GmbH Company Overview
5.2 AngioDynamics Inc Company Overview
5.3 Cardiovascular Systems Inc Company Overview
5.4 Echopoint Medical Ltd Company Overview
5.5 Guerbet SA Company Overview
5.6 Navis Medical Company Overview
5.7 Rontis AG Company Overview
5.8 Scientia Vascular LLC Company Overview
5.9 SoundBite Medical Solutions Inc Company Overview
6 Peripheral Guidewires- Recent Developments
6.1 Nov 23, 2021: OpSens Announces Fourth Quarter And Fiscal Year 2021 Financial Results
6.2 Nov 17, 2021: OpSens to Host Fourth Quarter Fiscal Year 2021 Financial Results Conference Call and Year-End Update on Tuesday, November 23, 2021
6.3 Nov 12, 2021: Asahi Intecc Announces Financial Results for the First Quarter of the Fiscal Year Ending June 2022
6.4 Nov 09, 2021: Rodrigo Santos Named Member of the Board of Management, Bayer AG, and President of the Crop Science Division
6.5 Nov 08, 2021: Boston Scientific Announces Upcoming Conference Schedule
6.6 Nov 04, 2021: Bayer announces Christoph Koenen as new Global Head of Clinical Development and Operations within Pharmaceuticals Research and Development at Bayer
6.7 Nov 04, 2021: Terumo Corp Half Yearly Results For the Period 30 September 2021
6.8 Nov 02, 2021: Cordis Names Muscari President Of The Americas
6.9 Nov 01, 2021: Japan Lifeline Announces FY3/2022 2Q Financial Results
6.10 Oct 28, 2021: Stereotaxis to Report Third Quarter 2021 Financial Results on November 11, 2021
6.11 Oct 28, 2021: Merit Medical Reports Results For Quarter Ended September 30, 2021
6.12 Oct 27, 2021: Boston Scientific Announces Results For Third Quarter 2021
6.13 Oct 05, 2021: Merit Medical Systems to Announce Third Quarter Results on October 28, 2021
6.14 Sep 29, 2021: OpSens to Present at the Lytham Partners Fall 2021 Investor Conference
6.15 Sep 09, 2021: Merit Medical Systems to Announce First Quarter Results on April 29, 2021
6.16 Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting
6.17 Aug 04, 2021: Terumo Revises its Full-Year Financial Guidance for FY2021
6.18 Aug 04, 2021: Japan Lifeline Announces FY3/2022 1Q Financial Results
6.19 Aug 04, 2021: Terumo Corp. Announces Consolidated Financial Results for the First Quarter Ended June 30, 2021
6.20 Jul 27, 2021: Cardiovascular Systems to Attend Three Investor Conferences in August
6.21 Jul 26, 2021: Stereotaxis Strengthens Board of Directors with Appointment of Myriam J. Curet, M.D.
6.22 Jul 20, 2021: Stereotaxis to Report Second Quarter 2021 Financial Results on August 10, 2021
6.23 Jul 13, 2021: AngioDynamics Reports Fiscal 2021 Fourth Quarter and Full-Year Financial Results
6.24 Jul 09, 2021: Merit Medical Systems to Announce Second Quarter Results on July 29, 2021
6.25 Jun 25, 2021: Japan Lifeline Notice of Resolution of the 41st Annual General Meeting of Shareholders
6.26 May 26, 2021: Bayer joins Greentown Labs' Corporate Partner Network
6.27 May 24, 2021: Boston Scientific to Participate in Bernstein's 37th Annual Strategic Decisions Conference
6.28 May 14, 2021: Asahi Intecc Announces Financial Results and Presentation Materials for the 3rd Quarter of the Fiscal Year ending June 2021
6.29 May 14, 2021: Asahi Intecc announces third and fourth half of the financial statements for the June period of 2021
6.30 Mar 30, 2021: AngioDynamics Reports Fiscal 2021 Third Quarter Financial Results and Updates Guidance
6.31 Mar 29, 2021: Merit Medical Reports Results for Quarter Ended March 31, 2021
6.32 Mar 24, 2021: Cardiovascular Systems to Participate at the 20th Annual Needham Healthcare Conference
6.33 Mar 22, 2021: OpSens to Present at Lytham Partners Spring 2021 Investor Conference
6.34 Mar 22, 2021: Terumo and Allied Telesis jointly develop a smooth operating environment for infusion systems
6.35 Mar 01, 2021: AngioDynamics to Present at the Barclays Virtual Global Healthcare Conference
6.36 Feb 17, 2021: Medtronic Executives to Speak at Upcoming Investor Conferences
6.37 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021
6.38 Feb 12, 2021: Merit Medical Systems to Announce Fourth Quarter and Year End 2020 Results on February 24, 2021
6.39 Feb 12, 2021: Boston Scientific Announces February and March 2021 Conference Schedule
6.40 Feb 10, 2021: Merit Medical to Present at 2021 SVB Leerink Global Healthcare Conference
6.41 Feb 04, 2021: Stereotaxis to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
6.42 Feb 04, 2021: Terumo announce Financial Statements
6.43 Feb 04, 2021: Terumo Announces Change of Directors and Executive Officers
6.44 Feb 03, 2021: Cardiovascular Systems, Inc. Reports Fiscal 2021 Second-quarter Financial Results
6.45 Feb 01, 2021: Cardiovascular Systems announces partnership with Chansu Vascular to develop new drug-coated balloon technology
6.46 Jan 07, 2021: Merit Medical to Participate in Two Upcoming Investor Conferences
6.47 Jan 06, 2021: OpSens to Host First Quarter Fiscal Year 2021 Financial Results Conference Call on Wednesday, January 13, 2021
6.48 Jan 06, 2021: Abbott Hosts Conference Call for Fourth-Quarter Earnings
6.49 Jan 04, 2021: AngioDynamics to Present at the J.P. Morgan Virtual Healthcare Conference
6.50 Dec 28, 2020: Cook Medical launches a new Customer Portal to enhance customer experience
7 Appendix
7.1 Methodology
7.2 About The Publisher
7.3 Contact The Publisher
7.4 Disclaimer
  • Peripheral Guidewires - Pipeline Products by Stage of Development
  • Peripheral Guidewires - Pipeline Products by Segment
  • Peripheral Guidewires - Pipeline Products by Territory
  • Peripheral Guidewires - Pipeline Products by Regulatory Path
  • Peripheral Guidewires - Pipeline Products by Estimated Approval Date
  • Peripheral Guidewires - Ongoing Clinical Trials
  • Peripheral Guidewires Companies - Pipeline Products by Stage of Development
  • Peripheral Guidewires - Pipeline Products by Stage of Development
  • Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Adrion MRI Guidewire - Product Status
  • Adrion MRI Guidewire - Product Description
  • AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Adx - Product Status
  • Adx - Product Description
  • Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Next Gen Guide Wire - Product Status
  • Next Gen Guide Wire - Product Description
  • PAD Radial Guidewire - Product Status
  • PAD Radial Guidewire - Product Description
  • Echopoint Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • iKOs Guidewire - Peripheral Vascular - Product Status
  • iKOs Guidewire - Peripheral Vascular - Product Description
  • Guerbet SA Pipeline Products & Ongoing Clinical Trials Overview
  • Microguidewire - Product Status
  • Microguidewire - Product Description
  • Navis Medical Pipeline Products & Ongoing Clinical Trials Overview
  • Variable Control Guidewire System - Product Status
  • Variable Control Guidewire System - Product Description
  • Rontis AG Pipeline Products & Ongoing Clinical Trials Overview
  • Peripheral Guidewire - 0.035 - Product Status
  • Peripheral Guidewire - 0.035 - Product Description
  • Scientia Vascular LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Zoom 14 Guidewire - Product Status
  • Zoom 14 Guidewire - Product Description
  • SoundBite Medical Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
  • SoundBite Crossing System - Peripheral - ATK - Product Status
  • SoundBite Crossing System - Peripheral - ATK - Product Description
  • SoundBite Crossing System - Peripheral - BTK - Product Status
  • SoundBite Crossing System - Peripheral - BTK - Product Description
  • SoundBite Medical Solutions Inc - Ongoing Clinical Trials Overview
  • SoundBite Crossing System - Peripheral - BTK - Prospective Study on the Clinical Effectiveness, Safety, Cost Benefits and Outcomes of the SoundBite Crossing System in Complex Peripheral CTOs - The PROSPECTOR II Study
  • Glossary

  • Peripheral Guidewires - Pipeline Products by Stage of Development
  • Peripheral Guidewires - Pipeline Products by Segment
  • Peripheral Guidewires - Pipeline Products by Territory
  • Peripheral Guidewires - Pipeline Products by Regulatory Path
  • Peripheral Guidewires - Pipeline Products by Estimated Approval Date
  • Peripheral Guidewires - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Andramed GmbH
  • AngioDynamics Inc
  • Cardiovascular Systems Inc
  • Echopoint Medical Ltd
  • Guerbet SA
  • Navis Medical
  • Rontis AG
  • Scientia Vascular LLC
  • SoundBite Medical Solutions Inc